Literature DB >> 11334724

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

J M Ververs1, R M Roumen, A J Vingerhoets, G Vreugdenhil, J W Coebergh, M A Crommelin, E J Luiten, O J Repelaer van Driel, M Schijven, J C Wissing, A C Voogd.   

Abstract

The aim of this study was to investigate the nature and severity of the arm complaints among breast cancer patients after axillary lymph node dissection (ALND) and to study the effects of this treatment-related morbidity on daily life and well-being. 400 women, who underwent ALND as part of breast cancer surgery, filled out a treatment-specific quality of life questionnaire. The mean time since ALND was 4.7 years (range 0.3-28 years). More than 20% of patients reported pain, numbness, or loss of strength and 9% reported severe oedema. None of the complaints appeared to diminish over time. Irradiation of the axilla and supraclavicular irradiation were associated with a 3.57-fold higher risk of oedema (odds ratio (OR) 3.57; 95% confidence interval (CI) 1.66-7.69) causing many patients to give up leisure activities or sport. Women who underwent irradiation of the breast or chest wall more often reported to have a sensitive scar than women who did not receive radiotherapy. Women <45 years of age had an approximately 6 times higher risk of numbness of the arm (OR 6.49; 95% CI 2.58-16.38) compared with those > or = 65 years of age; they also encountered more problems doing their household chores. The results of the present study support the introduction of less invasive techniques for the staging of the axilla, sentinel node biopsy being the most promising.

Entities:  

Mesh:

Year:  2001        PMID: 11334724     DOI: 10.1016/s0959-8049(01)00067-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.

Authors:  Ira L Savetsky; Jeremy S Torrisi; Daniel A Cuzzone; Swapna Ghanta; Nicholas J Albano; Jason C Gardenier; Walter J Joseph; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

2.  Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years.

Authors:  René Aloisio da Costa Vieira; Allini Mafra da Costa; Josue Lopes de Souza; Rafael Richieri Coelho; Cleyton Zanardo de Oliveira; Almir José Sarri; Renato José Affonso Junior; Gustavo Zucca-Matthes
Journal:  Breast Care (Basel)       Date:  2015-12-14       Impact factor: 2.860

3.  Breast Cancer EDGE Task Force Outcomes: Clinical Measures of Pain.

Authors:  Shana Harrington; Laura Gilchrist; Antoinette Sander
Journal:  Rehabil Oncol       Date:  2014

4.  Quality indicators for sentinel lymph node biopsy: is there room for improvement?

Authors:  Sergio A Acuna; Fernando A Angarita; David R McCready; Jaime Escallon
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

5.  Risk of decline in upper-body function and symptoms among older breast cancer patients.

Authors:  Jennifer L Westrup; Timothy L Lash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

Review 6.  Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies.

Authors:  Li Wang; Gordon H Guyatt; Sean A Kennedy; Beatriz Romerosa; Henry Y Kwon; Alka Kaushal; Yaping Chang; Samantha Craigie; Carlos P B de Almeida; Rachel J Couban; Shawn R Parascandalo; Zain Izhar; Susan Reid; James S Khan; Michael McGillion; Jason W Busse
Journal:  CMAJ       Date:  2016-07-11       Impact factor: 8.262

7.  Cost-effectiveness of positron emission tomography in breast cancer.

Authors:  J Scott Sloka; Peter D Hollett; Maria Mathews
Journal:  Mol Imaging Biol       Date:  2005 Sep-Oct       Impact factor: 3.488

8.  Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.

Authors:  Kimberly Stephens; Bruce A Cooper; Claudia West; Steven M Paul; Christina R Baggott; John D Merriman; Anand Dhruva; Kord M Kober; Dale J Langford; Heather Leutwyler; Judith A Luce; Brian L Schmidt; Gary M Abrams; Charles Elboim; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Bradley E Aouizerat
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

9.  Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life.

Authors:  Sandra C Hayes; Sheree Rye; Diana Battistutta; Tracey DiSipio; Beth Newman
Journal:  Health Qual Life Outcomes       Date:  2010-08-31       Impact factor: 3.186

Review 10.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.